 Orgenesis NASDAQ:ORGS Inc said that a consortium led by its subsidiary, MIDA Biotech, has won a 4-million-euro grant under the European Innovation Council Pathfinder Challenge Program which supports cutting-edge science and technology in order to create new market opportunities. The consortium members include MIDA Biotech B.V. 